Volitionrx (VNRX) Income from Continuing Operations (2019 - 2025)
Volitionrx (VNRX) has disclosed Income from Continuing Operations for 9 consecutive years, with 5100830.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Income from Continuing Operations fell 10741.53% year-over-year to 5100830.0, compared with a TTM value of 16373427.0 through Sep 2025, up 32.19%, and an annual FY2024 reading of 27015023.0, up 24.74% over the prior year.
- Income from Continuing Operations was 5100830.0 for Q3 2025 at Volitionrx, down from 29992.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 94092.0 in Q4 2022 and bottomed at 9521927.0 in Q2 2023.
- Average Income from Continuing Operations over 5 years is 3535572.32, with a median of 47049.0 recorded in 2024.
- The sharpest move saw Income from Continuing Operations soared 791.1% in 2022, then tumbled 12585.14% in 2023.
- Year by year, Income from Continuing Operations stood at 73088.0 in 2021, then grew by 28.74% to 94092.0 in 2022, then plummeted by 9380.53% to 8732237.0 in 2023, then soared by 33.8% to 5781027.0 in 2024, then increased by 11.77% to 5100830.0 in 2025.
- Business Quant data shows Income from Continuing Operations for VNRX at 5100830.0 in Q3 2025, 29992.0 in Q2 2025, and 5521562.0 in Q1 2025.